ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	5/47	30/7206	1.19692767004e-06
ko04612	Antigen processing and presentation	5/47	77/7206	0.000132021403497
ko03050	Proteasome	4/47	54/7206	0.000395728575534
ko04640	Hematopoietic cell lineage	4/47	64/7206	0.000758067498543
ko04060	Cytokine-cytokine receptor interaction	6/47	191/7206	0.00139283278529
ko04142	Lysosome	5/47	151/7206	0.00285443974749
ko00511	Other glycan degradation	2/47	26/7206	0.0122497504584
ko00062	Fatty acid elongation	2/47	33/7206	0.0193347358955
ko04662	B cell receptor signaling pathway	3/47	88/7206	0.0193862305579
ko04145	Phagosome	4/47	162/7206	0.0207403258151
ko05150	Staphylococcus aureus infection	2/47	36/7206	0.0227867666674
ko04658	Th1 and Th2 cell differentiation	3/47	96/7206	0.0243482589785
ko04064	NF-kappa B signaling pathway	3/47	96/7206	0.0243482589785
ko04650	Natural killer cell mediated cytotoxicity	3/47	97/7206	0.025012549741
ko04620	Toll-like receptor signaling pathway	3/47	100/7206	0.027064129448
ko04659	Th17 cell differentiation	3/47	106/7206	0.0314309242846
ko05152	Tuberculosis	4/47	187/7206	0.0329082414765
ko04062	Chemokine signaling pathway	4/47	201/7206	0.0412314152944
ko04660	T cell receptor signaling pathway	3/47	124/7206	0.0466132329211
ko05145	Toxoplasmosis	3/47	126/7206	0.0484892313841